Company Profile
Alkermes plc Stock Price, News & Catalysts
- Ticker:
- ALKS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Ireland
Stock performance
44.54 USD (-2.94%)
Close
Last updated: November 5, 2026
6.89B USD
Market cap
Why the stock is moving
Following the latest company update, “Alkermes Showcases Research From Psychiatry and Sleep Portfolios at the Neuroscience Education Institute Fall Congress”, ALKS closed down 2.94% at $44.54 on Nov 5, 2026. The move occurred in the trading session associated with this company update.
Company overview
Business overview
Alkermes is a biopharmaceutical company focused on neuroscience, addiction medicine, and specialty therapeutics. Its portfolio combines commercial products and development programs across CNS and related areas.
Geographic Base and Sector Classification
Alkermes is headquartered in Ireland and listed on NASDAQ. It has a global footprint with a strong U.S. commercial base.
Business Model Characteristics
The company generates value through product sales, neuroscience development, and lifecycle management across a specialty portfolio. Investors watch commercial execution, pipeline progress, and strategic allocation.
Position Within the Biotechnology Landscape
Alkermes sits in the upper tier of specialty neuroscience biotech. It is more durable than a pure development-stage name, but catalyst events still matter to the story.
Future catalysts
- Alkermes’ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the company’s growth mix. Investors will watch whether the commercial base stays durable.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Alkermes plc (ALKS)?
Alkermes plc (ALKS) most recently closed at 44.54 USD, a -2.94% move versus the previous session.
What is the market cap of Alkermes plc (ALKS)?
Alkermes plc currently has a market capitalization of 6.89B USD on BioPharmSignal.
What does Alkermes plc do?
Alkermes is a biopharmaceutical company focused on neuroscience, addiction medicine, and specialty therapeutics. Its portfolio combines commercial products and development programs across CNS and related areas.
On which exchange is ALKS stock listed?
Alkermes plc (ALKS) is associated with NASDAQ, Ireland, Biopharma.
What is Alkermes?
Alkermes’ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the company’s growth mix.
Which conditions is Alkermes plc targeting with Alkermes?
Alkermes plc is associated with neuroscience based on its company overview and current catalyst commentary.
How does Alkermes plc describe recent progress with Alkermes?
Alkermes’ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the company’s growth mix.
What is Lybalvi?
Alkermes’ catalysts are VIVITROL, Lybalvi, and any CNS pipeline update that broadens the company’s growth mix.